Mia's Feed
Medical News & Research

High-markup Hospitals Have Worse Patient Outcomes Despite Higher Charges

High-markup Hospitals Have Worse Patient Outcomes Despite Higher Charges

Share this article

A new UCLA study reveals that hospitals with higher charges often have poorer patient outcomes, highlighting the need for transparency and regulation in healthcare pricing.

2 min read

Recent research from UCLA has shed light on the troubling correlation between hospital pricing strategies and patient health results. The study highlights that hospitals charging significantly higher prices for services—particularly for-profit and investor-owned institutions located in major metropolitan areas—tend to have considerably poorer patient outcomes compared to lower-cost hospitals. These high-markup hospitals, which mark up charges up to 17 times their actual costs, make up about 10% of hospitals examined in the study.

The research, published in JAMA Surgery, analyzed data from nearly 2,000 U.S. hospitals performing major elective surgeries such as abdominal aortic aneurysm repair, colectomy, coronary artery bypass grafting, and hip replacement. Out of these, 196 hospitals were classified as high-markup, serving approximately 42,600 patients.

Patients treated at these high-markup facilities faced increased risks: they had a 45% higher chance of developing complications like cardiac, respiratory, infectious, or kidney issues, and a 33% greater likelihood of readmission within 30 days for non-elective reasons. Contrary to expectations, paying more did not translate into better care or outcomes—in fact, the data indicates worse results at these costly centers.

Dr. Sara Sakowitz, the lead researcher, emphasized that hospital prices impact everyone—patients, families, taxpayers, and health systems—especially when excessively high charges generate financial strain, including higher insurance premiums, deductibles, and potential medical bankruptcy. Transparency in pricing and outcomes is lacking, making it difficult for patients to make informed choices or for policymakers to regulate effectively.

The study underscores the need for increased price transparency, standardized reporting of hospital markups, and regulations—currently only in place in Maryland and West Virginia. Improving transparency would help patients understand costs upfront and enable comparisons of hospital quality and price. Ultimately, building a fairer, safer, and more accountable healthcare system requires addressing these disparities and ensuring that higher prices correlate with better outcomes.

source: https://medicalxpress.com/news/2025-09-high-markup-hospitals-significantly-worse.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Most US Children Enroll in Medicaid But Coverage Gaps Persist by Age 18

A comprehensive study shows that while most children in the US enroll in Medicaid or CHIP by age 18, many face coverage gaps, risking long-term access to essential health services amid recent policy changes.

Innovative Systems-Level Drug Design Promises More Effective Treatments for Aging and Chronic Diseases

New AI-driven research promises to revolutionize treatments for aging and chronic diseases by targeting multiple biological pathways simultaneously, offering hope for more effective therapies.

Innovative Nanotech Enables Quick Assessment of Fruit and Vegetable Vitamin C Levels

A new nanotechnology developed by the University of Queensland enables quick, easy assessment of vitamin C levels in fruits and vegetables using color-changing probes, with applications in food safety and sustainable agriculture.

Innovative Fluorescent Dye Technique Enhances Prediction of Oral Cancer Progression

A groundbreaking study explores attaching fluorescent dyes to oral cancer biomarkers to improve early detection and targeted treatment of premalignant and malignant lesions, promising enhanced prediction of cancer progression.